Antagonistic anti-HTNFSF13B human antibodies
Details for Australian Patent Application No. 2002322436 (hide)
International Classifications
Event Publications
16 January 2003 Complete Application Filed
Priority application(s): 60/312,808 16.08.01 US
29 May 2003 Application Open to Public Inspection
Published as AU-B-2002322436
4 December 2008 Application Accepted
Published as AU-B-2002322436
2 April 2009 Standard Patent Sealed
31 March 2011 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 09 Mar 2011. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2004
1 September 2011 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 09 Mar 2011 2003
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002322437-OLIGONUCLEOTIDE THERAPEUTICS FOR TREATING HEPATITIS C VIRUS INFECTIONS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser